Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Kaspi.kz AO (KSPIq)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
120.60 +0.00    +0.00%
22/03 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 100.00 / 140.00
  • Day's Range: 117.20 - 120.60
Type:  Equity
Market:  United Kingdom
ISIN:  US48581R2058 
SEDOL:  BMXZ8G7
Kaspi.kz AO 120.60 +0.00 +0.00%

LON:KSPIq Financials

 
This summary provides an overview of the most significant critical numbers from each of the Kaspi.kz AO financial reports, including theKaspi.kz AO income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the LON:KSPIq financials over time via breakdowns of their annual reports.

Joint Stock Company Kaspi.kz reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was KZT 571,353 million compared to KZT 392,900 million a year ago. Net income was KZT 247,993 million compared to KZT 188,249 million a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

KSPIq Income Statement & Profits

Gross margin TTM 89.03%
Operating margin TTM 78.27%
Net Profit margin TTM 44.22%
Return on Investment TTM 91.09%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 552814 570718 502185 439257
Gross Profit 483405 504116 454488 396388
Operating Income 414596 434645 397269 347204
Net Income 223440 244278 231156 192814

KSPIq Balance Sheet

Quick Ratio MRQ 4.13
Current Ratio MRQ -
LT Debt to Equity MRQ 16%
Total Debt to Equity MRQ 29.52%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 6909226 6821932 6079275 5828059
Total Liabilities 5550638 5718719 5069829 4902411
Total Equity 1358588 1103213 1009446 925648

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 5,842.22
Revenue/Share TTM 10,882.43
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 436066 -112326 554450
Cash From Investing Activities 54816 247200 -275188
Cash From Financing Activities -182560 -152540 -273225
Net Change in Cash 291951 1235 6442
* In Millions of KZT (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KSPIq Price Commentary

Write your thoughts about Kaspi.kz AO
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email